Condition
Persistent Vegetative State
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed3
Unknown1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06081283Phase 4Terminated
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
NCT03706170Not ApplicableCompletedPrimary
Emotion Assessment to Study Consciousness in Awakening Patients
NCT02999490Not ApplicableCompletedPrimary
18F-FDG PET/CT in Diagnostic Patients of Disorder of Consciousness
NCT02566720Not ApplicableUnknown
Amantadine and Functional Improvement Following ABI Measured by MRI Tractography; A Pilot Study
NCT00121004Completed
A Study to Tailor Advance Directives
Showing all 5 trials